Characterization of hepatitis B virus surface antigen particles expressed in stably transformed mammalian cell lines containing the large, middle and small surface protein | ||
| dc.conicet.organizacion | Universidad Nacional del Litoral | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe | |
| dc.conicet.organizacion | Universidad Nacional del Litoral | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe | |
| dc.conicet.organizacion | Universidad Nacional del Litoral | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe | |
| dc.conicet.organizacion | Universidad Nacional del Litoral | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe | |
| dc.conicet.organizacion | Universidad Nacional del Litoral | |
| dc.conicet.organizacion | Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe | |
| dc.contributor.author | Battagliotti, Juan Manuel | |
| dc.contributor.author | Fontana, Diego Sebastian | |
| dc.contributor.author | Etcheverrigaray, Marina | |
| dc.contributor.author | Kratje, Ricardo Bertoldo | |
| dc.contributor.author | Prieto, Claudio | |
| dc.date.issued | 2020-11 | |
| dc.description.abstract | Vaccination still represents the most efficient and inexpensive strategy in the control of hepatitis B virus (HBV) infection. However, about 10% of the population vaccinated with the current yeast derived vaccine, consisting of the non-glycosylated form of the small envelope protein (S) of the HBV, fail to display an adequate immune response. Therefore, there is a need for the development of new vaccines with enhanced immunogenicity. On this regard, new generation vaccines containing L and preS2-containing HBV surface proteins in addition to S, have proven to be able to bypass the lack of response of the standard vaccine. In this work, we describe the development of stable recombinant CHO–K1 and HEK293 cell lines able to produce and secrete hepatitis B subviral envelope particles (HBV-SVPs) composed by the three surface proteins of the HBV. In turn, we demonstrated that these particles induced a specific humoral immune response in experimental animals and triggered the production of antibodies with the ability to recognize the binding site of HBV with the hepatocyte. Thus, these HBV-SVPs represent a promising candidate as a new generation vaccine in order to enhance the immunogenicity of the conventional yeast derived HBV vaccine. | es |
| dc.description.fil | Fil: Battagliotti, Juan Manuel. Universidad Nacional del Litoral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina | |
| dc.description.fil | Fil: Fontana, Diego Sebastian. Universidad Nacional del Litoral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina | |
| dc.description.fil | Fil: Etcheverrigaray, Marina. Universidad Nacional del Litoral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina | |
| dc.description.fil | Fil: Kratje, Ricardo Bertoldo. Universidad Nacional del Litoral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina | |
| dc.description.fil | Fil: Prieto, Claudio. Universidad Nacional del Litoral; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina | |
| dc.format | application/pdf | es |
| dc.identifier.citation | Battagliotti, Juan Manuel; Fontana, Diego Sebastian; Etcheverrigaray, Marina; Kratje, Ricardo Bertoldo; Prieto, Claudio; Characterization of hepatitis B virus surface antigen particles expressed in stably transformed mammalian cell lines containing the large, middle and small surface protein; Elsevier Science; Antiviral Research; 183; 11-2020; 1-9 | es |
| dc.identifier.institucional | CONICET | |
| dc.identifier.issn | 0166-3542 | es |
| dc.identifier.repo | CONICET Digital | |
| dc.identifier.uri | http://hdl.handle.net/11336/151044 | |
| dc.journal.ciudad | Amsterdam | es |
| dc.journal.pagination | 1-9 | es |
| dc.journal.pais | Países Bajos | es |
| dc.journal.title | Antiviral Research | es |
| dc.journal.volume | 183 | es |
| dc.language.iso | eng | es |
| dc.publisher | Elsevier Science | es |
| dc.relation.alternativeid | info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1016/j.antiviral.2020.104936 | |
| dc.rights | info:eu-repo/semantics/restrictedAccess | * |
| dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/2.5/ar/ | * |
| dc.subject | HEPATITIS B | es |
| dc.subject | MAMMALIAN CELLS | es |
| dc.subject | NEW GENERATION VACCINE | es |
| dc.subject | STABLE RECOMBINANT CELL LINES | es |
| dc.subject | SUBVIRAL PARTICLES | es |
| dc.subject.classification | Biotecnología relacionada con la Salud | es |
| dc.subject.classification | Biotecnología de la Salud | es |
| dc.subject.classification | CIENCIAS MÉDICAS Y DE LA SALUD | es |
| dc.title | Characterization of hepatitis B virus surface antigen particles expressed in stably transformed mammalian cell lines containing the large, middle and small surface protein | es |
| dc.type | info:eu-repo/semantics/article | |
| dc.type | info:ar-repo/semantics/artículo | |
| dc.type | info:eu-repo/semantics/publishedVersion | |
Archivos
Bloque original
Cargando...
- Nombre:
- CONICET_Digital_Nro.7f525f58-0799-41fb-a04d-d9a51017ea99_A.pdf
- Tamaño:
- 4.72 MB
- Formato:
- Adobe Portable Document Format